FDA Inspection 955623 — Noven Pharmaceuticals, Inc.

Noven Pharmaceuticals, Inc. — FEI 3008855976

The FDA completed an inspection of Noven Pharmaceuticals, Inc. on Jan 13, 2016 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 13, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.